Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pharmacol Res ; 38(4): 289-95, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9774492

RESUMO

The involvement of toxic oxygen intermediates in the bacteriostatic effects of mycotoxins (T-2 toxin, deoxynivalenol, ochratoxin A, aflatoxin B1, and fumonisin B1) was investigated by producing bacterial growth curves using turbidimetry assays in the presence and absence of oxygen radical-scavenging substances. The strains used in this study included Escherichia coli (FT 101), Streptococcus agalactiae (FT 311, FT 313, FT 315), Staphylococcus aureus (FT 192), Yersinia enterocolitica (FT 430), Salmonella infantis (FT 431), Erysipelothrix rhusiopathiae (FT 432), Lactobacillus plantarum (FT234) and Lactobacillus casei (FT 232). Tamoxifen, melatonin, l-carnitine and coenzyme Q10 were used as radical scavengers against oxygen toxicity to the strains studied. Tamoxifen was the most effective in inhibiting bacterial growth when used at a high concentration, whereas melatonin and l-carnitine were less effective. A combination of l-carnitine and coenzyme Q10 provided better protection against oxygen toxicity caused by the mycotoxins growth than they did individually. It was concluded that oxygen radicals are involved in the killing of bacteria and that there is endogenous formation of toxic oxygen products by mycotoxins. The objective of this study was to determine whether the antioxidants were able to counteract the toxic effects of the mycotoxins. The data obtained indicate that bacterial growth can be inhibited especially by T-2 toxin, aflatoxin B1 and ochratoxin A and that this effect can be partially counteracted by antioxidants such as coenzyme Q10 plus l-carnitine.


Assuntos
Antineoplásicos Hormonais/farmacologia , Antioxidantes/farmacologia , Bactérias/citologia , Bactérias/efeitos dos fármacos , Fumonisinas , Micotoxinas/toxicidade , Tamoxifeno/farmacologia , Aflatoxina B1/toxicidade , Ácidos Carboxílicos/toxicidade , Carnitina/farmacologia , Divisão Celular/efeitos dos fármacos , Coenzimas , Relação Dose-Resposta a Droga , Erysipelothrix/citologia , Erysipelothrix/efeitos dos fármacos , Escherichia coli/citologia , Escherichia coli/efeitos dos fármacos , Lactobacillus/citologia , Lactobacillus/efeitos dos fármacos , Lacticaseibacillus casei/citologia , Lacticaseibacillus casei/efeitos dos fármacos , Melatonina/farmacologia , Ocratoxinas/toxicidade , Salmonella/citologia , Salmonella/efeitos dos fármacos , Staphylococcus aureus/citologia , Staphylococcus aureus/efeitos dos fármacos , Streptococcus agalactiae/citologia , Streptococcus agalactiae/efeitos dos fármacos , Toxina T-2/toxicidade , Tricotecenos/toxicidade , Ubiquinona/análogos & derivados , Ubiquinona/farmacologia , Yersinia enterocolitica/citologia , Yersinia enterocolitica/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA